Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT05502458
Eligibility Criteria:
Inclusion Criteria:
* Age range: 18 to 75
* ASA: I-III
* primary liver cancer (CNLC: Stage I-IIIA)
* undergoing elective hepatectomy
Exclusion Criteria:
* Patients with severe bradycardia (HR \< 55bpm)
* patients with severe arrhythmias or cardiac dysfunction (EF \< 35%)
* patients with severe respiratory lung disease
* patients with severe liver and kidney insufficiency epilepsy
* patients with severe hyperlipidemia
* patients with a history of malignant hyperthermia
* patients with propofol or desflurane allergy
* patients with history of preoperative chemoradiotherapy
* patients who were on immunosuppressive treatment
* patients with chronic opioid therapy declined to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05502458
Study Brief:
Protocol Section:
NCT05502458